FCLAX (FCLAX) Stock Price & Analysis
FCLAX (FCLAX) rose 1.20% to USD 63.97 as of June 10, 2026 at 15:15 UTC, according to Nexqual real-time market data.
FCLAX last closed at USD 63.21; the session ranged USD 63.97–63.97 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 50.22–64.71 (NAS). Source: Nexqual, June 10, 2026 at 15:15 UTC.
Key Statistics (as of June 10, 2026 at 15:15 UTC)
| Price | USD 63.97 |
|---|---|
| Change | ▲ 1.20% (up) |
| Previous Close | USD 63.21 |
| Open | USD 63.97 |
| Day Range | USD 63.97 – 63.97 |
| 52-Week Range | USD 50.22 – 64.71 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FCLAX)
Nexqual's technical model rates FCLAX "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 15:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.39 (neutral) |
| vs SMA50 | Above (USD 62.4) |
| MACD | 0.29 (positive) |
Financial Health Score (FCLAX)
Nexqual rates FCLAX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 15:15 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FACDX | Fidelity Advisor Series VII: Fi | USD 55.57 | ▲ 2.77% |
| FMFAX | Fidelity Advisor Materials Fund | USD 99.66 | ▲ 1.21% |
| FDAGX | Fidelity Advisor Consumer Stapl | USD 90.37 | ▲ 1.29% |
| FBTAX | Fidelity Advisor Biotechnology | USD 38.35 | ▲ 2.76% |
| FAFDX | Fidelity Advisor Series VII: Fi | USD 37.72 | ▲ 1.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 15:15 UTC. This page is informational and not investment advice.